Integrative Biomedical Research

Integrative Biomedical Research (Journal of Angiotherapy) | Online ISSN  3068-6326
463
Citations
1.8m
Views
758
Articles
Submit
  1. You are here:
  2. Home
  3. Journals
  4. Journal of Angiotherapy
Your new experience awaits. Try the new design now and help us make it even better
Switch to the new experience
Journal of Angiotherapy

Volume 10 Number 1 2026

Article Contents

RESEARCH ARTICLE   (Open Access)
Contents Vol 10 (1)

Why Artificial Intelligence Models for Antimicrobial Resistance Still Fail at the Bedside: A Review of Validation, Explainability, and Equity Gaps

Abstract References

Md. Kaium 1*, Suhel Ahmed 2

+ Author Affiliations

Integrative Biomedical Research 10 (1) 1-8 https://doi.org/10.25163/biomedical.10110889

Submitted: 05 June 2026 Revised: 20 August 2026  Accepted: 28 August 2026  Published: 30 August 2026 

Abstract

Artificial intelligence (AI) and machine learning (ML) models now predict antimicrobial resistance (AMR) phenotypes with striking accuracy in retrospective, single-centre studies — and yet, curiously, almost none of them have made it as far as routine clinical use. This review set out to understand that gap, and, more usefully, what might close it. Following PRISMA 2020 guidance, we systematically synthesised peer-reviewed and preprint literature (2017–2026) on AI/ML applications for AMR prediction, mapping studies across four domains: comparative model performance, diagnostic input modality, data heterogeneity and algorithmic bias, and technological readiness in low- and middle-income countries (LMICs). Risk of bias was appraised using a PROBAST-informed framework. Tree-based ensembles and deep learning architectures achieved internal AUROC values of 0.89–0.99 across genomic and mass-spectrometric datasets; externally validated cohorts, however, showed a consistent 0.10–0.25 AUROC decay. Over 80% of publicly available pathogen genomic data originate from North America and Europe, while African isolates contribute under 2%. Calibration reporting and biologically validated explainability were almost entirely absent from the reviewed literature, and One Health data integration remained confined to fewer than 1% of studies. Taken together, these findings suggest that the translational gap in AI-based AMR prediction is not, at its core, a modelling problem — it is a problem of representativeness, validation rigour, and earned clinical trust. Closing it will require external and prospective validation as a reporting norm, calibrated and biologically grounded explainability, federated infrastructure inclusive of LMIC data, and tiered, offline-capable deployment pathways suited to resource-limited settings.

Keywords: antimicrobial resistance; machine learning; external validation; explainable AI; health equity

References

Abbas, M. M., Ranjan, A., Hou, A., & Mukhopadhyay, S. (2024). Trans-ARG: Predicting antibiotic resistance genes with a transformer-based model and pretrained protein language model. In Proceedings of the 4th International Conference on AI-ML Systems (pp. 1–8). Association for Computing Machinery. https://doi.org/10.1145/3703412.3703425

Ahvar, N., Mohammadi, M., Zafari, P., & Shokri, M. (2025). Artificial intelligence to combat antimicrobial resistance: Comparative benchmark of predictive methods. Journal of Medical and Biomedical Informatics, 15(2), 45–56.

Begum, A., Rahman, K., Sadia, H., Dey, S., Sharfuddin, M., Islam, M. T., … & Ahsan, S. F. (2026). The role of artificial intelligence in addressing antimicrobial resistance: Challenges, opportunities, and strategic interventions. International Journal of Pharmaceutical Research and Technology, 16(2), 57–69.

Bhattacharya, R., Bose, D., Siddique, K. R., Rodriguez, R. V., & Ray, A. (2026). Artificial intelligence for sustainable solutions in combating antimicrobial resistance through data driven health innovations. Discover Public Health, 23(1), 10.

Bilal, H., Khan, M. N., Khan, S., Shafiq, M., Fang, W., Khan, R. U., Rahman, M. U., Li, X., Lv, Q.-L., & Xu, B. (2025). The role of artificial intelligence and machine learning in predicting and combating antimicrobial resistance. Computational and Structural Biotechnology Journal, 27, 423–439. https://doi.org/10.1016/j.csbj.2025.01.006

Boudza, R., Bounou, S., Segura-Garcia, J., Moukadiri, I., & Maicas, S. (2026). Artificial intelligence as a catalyst for antimicrobial discovery: From predictive models to de novo design. Microorganisms, 14, 394. https://doi.org/10.3390/microorganisms1400394-v2

Chen, C., Li, S.-L., Xu, Y.-Y., Liu, J., Graham, D. W., & Zhu, Y.-G. (2024). Characterising global antimicrobial resistance research explains why One Health solutions are slow in development: An application of AI-based gap analysis. Environment International, 187, 108680. https://doi.org/10.1016/j.envint.2024.108680

Condorelli, C., Nicitra, E., Musso, N., Bongiorno, D., Stefani, S., Gambuzza, L. V., et al. (2024). Prediction of antimicrobial resistance of Klebsiella pneumoniae from genomic data through machine learning. PLoS ONE, 19(9), Article e0309333. https://doi.org/10.1371/journal.pone.0309333

Cuteri, V., Storoni, C., Cao, S., & Li, Y. (2026). Artificial intelligence-driven phage therapy in veterinary medicine: An adaptive One Health strategy to mitigate antimicrobial resistance in livestock systems. Frontiers in Veterinary Science, 13, Article 1829777. https://doi.org/10.3389/fvets.2026.1829777

Dayan, I., Roth, H. R., Zhong, A., Harouni, A., Gentili, A., Abidin, Z. Z., et al. (2021). Federated learning for predicting clinical outcomes in patients with COVID-19. Nature Medicine, 27(10), 1735–1743. https://doi.org/10.1038/s41591-021-01505-1

Dong, Y., Hu, X., Huang, Z., & Deng, L. (2023). TGC-ARG: Predicting antibiotic resistance through transformer-based modeling and contrastive learning. In Proceedings of the IEEE International Conference on Bioinformatics and Biomedicine (BIBM) (pp. 17–26). IEEE. https://doi.org/10.1109/BIBM58861.2023.10385506

Hardan, S., Shaaban, M. A., Abdalla, J., & Yaqub, M. (2024). Affordable and realtime antimicrobial resistance prediction from multimodal electronic health records. Scientific Reports, 14(1), Article 16464. https://doi.org/10.1038/s41598-024-66812-5

Kasse, G. E., Cosh, S. M., Humphries, J., & Islam, M. S. (2025). Leveraging artificial intelligence for One Health: Opportunities and challenges in tackling antimicrobial resistance—scoping review. One Health Outlook, 7, 51. https://doi.org/10.1186/s42522-025-00170-8

Kiazolu, J. (2026a). Data heterogeneity and algorithmic bias in AI-based antimicrobial resistance prediction: A systematic review and mitigation framework. Research Square Systematic Review Preprint, 1–35. https://doi.org/10.21203/rs.3.rs-9552638/v1

Kiazolu, J. (2026b). Applications of artificial intelligence in antimicrobial resistance surveillance, prediction, and control in low- and middle-income countries: A scoping review. Research Square Scoping Review Preprint, 1–38. https://doi.org/10.21203/rs.3.rs-9876480/v1

Lin, T. H., Jian, M. J., Chung, H. Y., Chang, C. K., Perng, C. L., Chang, F. Y., et al. (2024). Machine-assisted prediction of ciprofloxacin resistance in clinical Stenotrophomonas maltophilia using mass spectra. Journal of Global Antimicrobial Resistance, 28, 110–118. https://doi.org/10.1016/j.jgar.2024.03.012

López-Cortés, X. A., Manríquez-Troncoso, J. M., Hernández-García, R., & Peralta, D. (2024). MSDeepAMR: Antimicrobial resistance prediction based on deep neural networks and transfer learning. Frontiers in Microbiology, 15, Article 1361795. https://doi.org/10.3389/fmicb.2024.1361795

Lyimo, B. (2026). Leveraging artificial intelligence to advance bioinformatics in Africa: Opportunities, challenges, and ethical considerations in combating antimicrobial resistance. Bioinformatics and Biology Insights, 20, 1–14. https://doi.org/10.1177/11779322261427123

Mohammed, A. M., Mohammed, M., Oleiwi, J. K., Osman, F. A., Adam, T., Betar, B. O., … & Ihmedee, F. H. (2025). Enhancing antimicrobial resistance strategies: Leveraging artificial intelligence for improved outcomes. South African Journal of Chemical Engineering, 51(1), 272–286.

Murray, C. J., Ikuta, K. S., Sharara, F., Swetschinski, L., Aguilar, G. R., Gray, A., et al. (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. The Lancet, 399(10325), 629–655.

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., et al. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, Article n71. https://doi.org/10.1136/bmj.n71

Pascucci, M., Royer, G., Adamek, J., Asmar, M. A., Aristizabal, D., Blanche, L., Bezzarga, A., Boniface-Chang, G., Brunner, A., Curel, C., Dulac-Arnold, G., Fakhri, R. M., Malou, N., Nordon, C., Runge, V., Samson, F., Sebastian, E., Soukieh, D., Vert, J. P., Ambroise, C., & Madoui, M. A. (2021). AI-based mobile application to fight antibiotic resistance. Nature Communications, 12(1), 1173. https://doi.org/10.1038/s41467-021-21187-3

Pennisi, F., Pinto, A., Ricciardi, G. E., Signorelli, C., & Gianfredi, V. (2025). The role of artificial intelligence and machine learning models in antimicrobial stewardship in public health: A narrative review. Antibiotics, 14(2), 134.

Ren, Y., Chakraborty, T., Doijad, S., Falgenhauer, L., Falgenhauer, J., Goesmann, A., & Chakravortty, D. (2021). Prediction of antimicrobial resistance based on whole-genome sequencing and machine learning. Bioinformatics, 38(2), 325–334. https://doi.org/10.1093/bioinformatics/btab681

Roy, D. (2026). Artificial intelligence and machine learning applications in antimicrobial resistance research: A systematic review. Research Square Systematic Review Preprint, 1–32. https://doi.org/10.21203/rs.3.rs-10478855/v1

Sanapalli, B. K. R., Palit, S., Deshpande, A., Tokala, R., Sigalapalli, D. K., & Sanapalli, V. (2026). Artificial intelligence and the discovery of antibiotics: Reinventing with opportunities, challenges, and clinical translation. Antibiotics, 15(2), 233.

Sardar, S., Dutta, S., Roychowdhury, P., Sikdar, P., Solanki, J., & Thangappan, J. (2026). Artificial intelligence for antimicrobial resistance: Advancing reproducibility, interpretability, and clinical deployment. Briefings in Bioinformatics, 27, Article bbag269. https://doi.org/10.1093/bib/bbag269

Shehata, Y. (2025). Artificial intelligence and deep learning for antimicrobial resistance prediction: A scoping review. IEEE Access, 13, 1154620.

Tharmakulasingam, M., Wang, W., Kerby, M., Ragione, R. L., & Fernando, A. (2023). TransAMR: An interpretable transformer model for accurate prediction of antimicrobial resistance using antibiotic administration data. IEEE Access, 11, 75337–75350. https://doi.org/10.1109/ACCESS.2023.3296221

Wang, N., Zhou, G., Li, S., & Zhang, H. (2025). Construction and validation of a predictive model for the risk of multidrug-resistant Klebsiella pneumoniae infection based on machine learning algorithms: A multicenter retrospective study. European Journal of Clinical Microbiology & Infectious Diseases, 44(8), 1889–1906. https://doi.org/10.1007/s10096-024-04987-1

Weis, C., Cuénod, A., Rieck, B., Dubuis, O., Graf, S., Lang, C., Oberle, M., Brackmann, M., Søgaard, K. K., Osthoff, M., Borgwardt, K., & Egli, A. (2022). Direct antimicrobial resistance prediction from clinical MALDI-TOF mass spectra using machine learning. Nature Medicine, 28(1), 164–174. https://doi.org/10.1038/s41591-021-01619-9

Ye, L., Ye, T., Zhang, Y., & Liu, Q. (2025). Deep learning-based species identification and antibiotic resistance gene detection using MALDI-TOF MS profiles. Advanced Intelligent Systems, 5, Article 2200235. https://doi.org/10.1002/aisy.202200235

Yong, D., Park, J. S., Kim, K., Seo, D., Kim, D.-C., Kim, J.-S., & Park, J.-M. (2025). Rapid screening of methicillin-resistant Staphylococcus aureus using MALDI-TOF MS and machine learning: A randomized, multicenter study. Analytical Chemistry, 97, 15667–15675. https://doi.org/10.1021/acs.analchem.5c02451

Yu, T., Xu, S., Sun, T., Lin, P., Gu, H., Wang, S., & Zhang, X. (2022). Rapid antimicrobial susceptibility testing of pathogens from blood cultures using surface-enhanced Raman scattering and machine learning. ACS Nano, 17(8), 7418–7432. https://doi.org/10.1021/acsnano.2c10584

Zarrin, E. K., Emami, S., & Karvani, S. (2025). Emerging deep learning solutions for multi-omics integration in ecological and clinical microbiology reviews. BiotechIntelect, 2(1), Article e10.


Article metrics
View details
0
Downloads
0
Citations
6
Views

View Dimensions


View Plumx


View Altmetric



0
Save
0
Citation
6
View
0
Share

Stay connected